dc.creator | Gallego-Durán, Rocío | es |
dc.creator | Cerro-Salido, Pablo | es |
dc.creator | Gómez-González, Emilio | es |
dc.date.accessioned | 2019-09-17T10:41:05Z | |
dc.date.available | 2019-09-17T10:41:05Z | |
dc.date.issued | 2016-08 | |
dc.identifier.citation | Gallego-Durán, R., Cerro-Salido, P. y Gómez-González, E., et al. (2016). Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease. Scientific Reports, 6, Article number: 31421. | |
dc.identifier.uri | https://hdl.handle.net/11441/89177 | |
dc.description.abstract | There is a need, in NAFLD management, to develop non-invasive methods to detect steatohepatitis (NASH) and to predict advanced fibrosis stages. We evaluated a tool based on optical analysis of liver magnetic resonance images (MRI) as biomarkers for NASH and fibrosis detection by investigating patients with biopsy-proven NAFLD who underwent magnetic resonance (MR) protocols using 1.5T General Electric (GE) or Philips devices. Two imaging biomarkers (NASHMRI and FibroMRI) were developed, standardised and validated using area under the receiver operating characteristic curve (AUROC) analysis. The results indicated NASHMRI diagnostic accuracy for steatohepatitis detection was 0.83 (95% CI: 0.73–0.93) and FibroMRI diagnostic accuracy for significant fibrosis determination was 0.85 (95% CI: 0.77–0.94). These findings were independent of the MR system used. We conclude that optical analysis of MRI has high potential to define non-invasive imaging biomarkers for the detection of steatohepatitis (NASHMRI) and the prediction of significant fibrosis (FibroMRI) in NAFLD patients. | es |
dc.description.sponsorship | Comisión Europea, 7º Programa Marco FP7/2007–2013 HEALTH-F2-2009-241762 Project Fatty Liver Inhibition of Progression (FLIP) | es |
dc.description.sponsorship | Junta de Andalucía, Consejería de Salud PI-0488-2012/2012 | es |
dc.format | application/pdf | es |
dc.language.iso | eng | es |
dc.publisher | Nature Publishing Group | es |
dc.relation.ispartof | Scientific Reports, 6, Article number: 31421. | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.title | Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease | es |
dc.type | info:eu-repo/semantics/article | es |
dcterms.identifier | https://ror.org/03yxnpp24 | |
dc.type.version | info:eu-repo/semantics/publishedVersion | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.contributor.affiliation | Universidad de Sevilla. Departamento de Física Aplicada III | es |
dc.relation.projectID | HEALTH-F2-2009-241762 | es |
dc.relation.projectID | PI-0488-2012/2012 | es |
dc.relation.publisherversion | https://www.nature.com/articles/srep31421 | es |
dc.identifier.doi | 10.1038/srep31421 | es |
dc.contributor.group | Universidad de Sevilla. TEP203: Fisica Interdisciplinar Fundamentos y Aplicaciones | es |
idus.format.extent | 9 p. | es |
dc.journaltitle | Scientific Reports | es |
dc.publication.volumen | 6 | es |
dc.publication.initialPage | Article number: 31421 | es |